Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 59

Results For "CHI"

5487 News Found

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
News | June 10, 2026

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027


NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Opinion | June 10, 2026

NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan

The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India


HAB Pharma targets Rs. 3,000 crore revenue by 2030
News | June 10, 2026

HAB Pharma targets Rs. 3,000 crore revenue by 2030

Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions


Remidio secures Gates Foundation grant to advance AI-powered retinal screening
Healthcare | June 10, 2026

Remidio secures Gates Foundation grant to advance AI-powered retinal screening

Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities


Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce
Policy | June 10, 2026

Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce

Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports


FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough
R&D | June 10, 2026

FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough

The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year


DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability excellence
Sustainability | June 10, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability excellence

Recognition places pharmaceutical excipients leader among the top 5% of companies globally, highlighting progress in emissions reduction, responsible sourcing, and sustainable supply chain practices


DePuy Synthes launches AI-powered hip surgery navigation system to streamline operating room workflow
News | June 10, 2026

DePuy Synthes launches AI-powered hip surgery navigation system to streamline operating room workflow

The company says the goal is to improve consistency and efficiency in total hip arthroplasty (THA) as demand for the procedure continues to surge


FibroFind appoints Lee Borthwick as CEO to drive global expansion
People | June 10, 2026

FibroFind appoints Lee Borthwick as CEO to drive global expansion

Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform


OET conducts Kerala workshop series to strengthen healthcare communication training
Healthcare | June 10, 2026

OET conducts Kerala workshop series to strengthen healthcare communication training

Three-city educator training programme equips teachers with practical strategies to improve healthcare English instruction and prepare professionals for global workforce demands